JP2010516817A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516817A5
JP2010516817A5 JP2009548391A JP2009548391A JP2010516817A5 JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5 JP 2009548391 A JP2009548391 A JP 2009548391A JP 2009548391 A JP2009548391 A JP 2009548391A JP 2010516817 A5 JP2010516817 A5 JP 2010516817A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009548391A
Other languages
English (en)
Japanese (ja)
Other versions
JP5566692B2 (ja
JP2010516817A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/052318 external-priority patent/WO2008094912A2/en
Publication of JP2010516817A publication Critical patent/JP2010516817A/ja
Publication of JP2010516817A5 publication Critical patent/JP2010516817A5/ja
Application granted granted Critical
Publication of JP5566692B2 publication Critical patent/JP5566692B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009548391A 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類 Expired - Fee Related JP5566692B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88741507P 2007-01-31 2007-01-31
US60/887,415 2007-01-31
PCT/US2008/052318 WO2008094912A2 (en) 2007-01-31 2008-01-29 Substituted gamma lactams as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2010516817A JP2010516817A (ja) 2010-05-20
JP2010516817A5 true JP2010516817A5 (https=) 2011-03-10
JP5566692B2 JP5566692B2 (ja) 2014-08-06

Family

ID=39639429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548391A Expired - Fee Related JP5566692B2 (ja) 2007-01-31 2008-01-29 治療薬としての置換ガンマラクタム類

Country Status (11)

Country Link
US (1) US7960381B2 (https=)
EP (1) EP2121672B1 (https=)
JP (1) JP5566692B2 (https=)
KR (1) KR101561706B1 (https=)
CN (1) CN101595106B (https=)
AU (1) AU2008210559B2 (https=)
BR (1) BRPI0808377B8 (https=)
CA (1) CA2676291C (https=)
MX (1) MX2009008039A (https=)
NZ (1) NZ578698A (https=)
WO (1) WO2008094912A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377984B2 (en) * 2008-01-29 2013-02-19 Allergan, Inc. Substituted gamma lactams as therapeutic agents
UA103616C2 (ru) * 2008-04-24 2013-11-11 Аллерган, Инк. Замещенные гамма-лактамы как терапевтические агенты
BRPI0910741A2 (pt) 2008-04-24 2015-09-29 Allergan Inc arilciclopentenos substituídos como agonistas de prostaglantina ep2
JP2011518834A (ja) * 2008-04-24 2011-06-30 アラーガン インコーポレイテッド 治療剤としての置換ガンマラクタム
CA2728229A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
EP2285775B1 (en) * 2008-05-20 2017-03-22 Allergan, Inc. Lactams and their use in the treatment of inter alia ocular hypertension or baldness

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2254726T3 (es) * 2001-07-16 2006-06-16 F. Hoffmann-La Roche Ag Analogos de prostaglandina como agonistas receptores de ep4.
NZ532519A (en) * 2001-11-05 2006-11-30 Allergan Inc Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
AU2003211574A1 (en) * 2002-03-05 2003-09-16 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7419999B2 (en) * 2002-06-10 2008-09-02 Applied Research Systems Ars Holding N.V. Gamma lactams as prostaglandin agonists and use thereof
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
EP1856042B1 (en) 2005-03-10 2012-06-27 Allergan, Inc. Substituted gamma lactams as therapeutic agents
EP1996546B1 (en) * 2006-03-20 2014-11-26 Allergan, Inc. Substituted gamma lactams as prostaglandin ep2 agonists

Similar Documents

Publication Publication Date Title
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2010516817A5 (https=)
JP2010524932A5 (https=)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2005112864A5 (https=)
JP2010077141A5 (https=)
JP2007533740A5 (https=)
JP2011504903A5 (https=)
JP2013542247A5 (https=)
JP2007517846A5 (https=)
JP2011516511A5 (https=)
JP2005539088A5 (https=)
JP2014521744A5 (https=)
JP2013508279A5 (https=)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2010523476A5 (https=)
JP2009543795A5 (https=)
JP2013544860A5 (https=)
JP2007302689A5 (https=)
EP1539734A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
JP2011512412A5 (https=)
JP2009540009A5 (https=)
JP2013500342A5 (https=)
JP2017511368A5 (https=)
JP2011509302A5 (https=)